Licensing Considerations and eCOA Vendor Collaborations

Episode 9 • January 30, 2024 • 00:26:26
Licensing Considerations and eCOA Vendor Collaborations
LifeSci Talks
Licensing Considerations and eCOA Vendor Collaborations

Jan 30 2024 | 00:26:26

/

Show Notes

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation Team at AbbVie, to cover the intricacies of clinical trial licensing, contract variations among eCOA providers, the importance of sponsor involvement, and the challenges of validated translations. Explore the complexities that can arise in these critical aspects of clinical trials

Other Episodes

Episode 2

March 23, 2026 • 00:23:33
Episode Cover

More Than an Aspiration: Building a Patient-Centric Evidence Strategy That Lasts

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Lina Eliasson PhD CPsycho, Founding Partner...

Listen

Episode 23

October 07, 2025 • 00:19:09
Episode Cover

Meaningful patient involvement in HTA decision making: where do we go from here?

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Alice Biggane, Outcomes Innovation and Research...

Listen

Episode 2

August 25, 2023 • 00:16:27
Episode Cover

Building a Successful Partnership: Meeting Sponsor Expectations with Aaron McCormick

Tune in to our chat with Aaron McCormick, Associate Director, eCOA Implementation at Moderna, to unravel the importance of standardized eCOA systems across trials...

Listen